Trial Profile
Active comparator stratified randomization study effect oral bepotastine besilate as new treatment for allergic rhinitis.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 24 Sep 2013
Price :
$35
*
At a glance
- Drugs Bepotastine (Primary) ; Leukotriene receptor antagonists
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- 23 Sep 2013 Status changed from not stated to recruiting as reported by University Hospital Medical Information Network - Japan.
- 12 Apr 2012 New trial record